

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 5.81447480 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.93925925 |
| 3 | regulation of fibrinolysis (GO:0051917) | 4.78594097 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.61758009 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.61758009 |
| 6 | regulation of protein activation cascade (GO:2000257) | 4.58909210 |
| 7 | exogenous drug catabolic process (GO:0042738) | 4.57481690 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.55335081 |
| 9 | phenylpropanoid metabolic process (GO:0009698) | 4.43867658 |
| 10 | regulation of complement activation (GO:0030449) | 4.43516491 |
| 11 | omega-hydroxylase P450 pathway (GO:0097267) | 4.13978873 |
| 12 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.07167771 |
| 13 | drug metabolic process (GO:0017144) | 4.06344512 |
| 14 | complement activation (GO:0006956) | 4.04660951 |
| 15 | negative regulation of protein activation cascade (GO:2000258) | 3.98613987 |
| 16 | negative regulation of complement activation (GO:0045916) | 3.98200259 |
| 17 | response to interferon-beta (GO:0035456) | 3.87171919 |
| 18 | protein activation cascade (GO:0072376) | 3.84246843 |
| 19 | urate metabolic process (GO:0046415) | 3.80888470 |
| 20 | valine metabolic process (GO:0006573) | 3.75016781 |
| 21 | drug transmembrane transport (GO:0006855) | 3.68939758 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 3.66570560 |
| 23 | cellular glucuronidation (GO:0052695) | 3.60760159 |
| 24 | regulation of triglyceride catabolic process (GO:0010896) | 3.56847896 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 3.56006203 |
| 26 | angiotensin maturation (GO:0002003) | 3.52570450 |
| 27 | glucuronate metabolic process (GO:0019585) | 3.51256474 |
| 28 | uronic acid metabolic process (GO:0006063) | 3.51256474 |
| 29 | L-phenylalanine metabolic process (GO:0006558) | 3.50901398 |
| 30 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.50901398 |
| 31 | L-phenylalanine catabolic process (GO:0006559) | 3.49672850 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.49672850 |
| 33 | ethanol metabolic process (GO:0006067) | 3.49319506 |
| 34 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.48766297 |
| 35 | phospholipid efflux (GO:0033700) | 3.46287985 |
| 36 | fibrinolysis (GO:0042730) | 3.37881748 |
| 37 | peptide catabolic process (GO:0043171) | 3.35619855 |
| 38 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.33502750 |
| 39 | aromatic amino acid family catabolic process (GO:0009074) | 3.33341541 |
| 40 | drug transport (GO:0015893) | 3.32982945 |
| 41 | response to interferon-alpha (GO:0035455) | 3.32697265 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 3.32667318 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 3.32667318 |
| 44 | macromolecular complex remodeling (GO:0034367) | 3.32667318 |
| 45 | bile acid metabolic process (GO:0008206) | 3.31771523 |
| 46 | glyoxylate metabolic process (GO:0046487) | 3.30286558 |
| 47 | negative regulation of humoral immune response (GO:0002921) | 3.27398457 |
| 48 | blood coagulation, intrinsic pathway (GO:0007597) | 3.26152207 |
| 49 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.25304341 |
| 50 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.25304341 |
| 51 | triglyceride homeostasis (GO:0070328) | 3.24775068 |
| 52 | acylglycerol homeostasis (GO:0055090) | 3.24775068 |
| 53 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.23610247 |
| 54 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.23109614 |
| 55 | cholesterol efflux (GO:0033344) | 3.22890938 |
| 56 | peptide hormone processing (GO:0016486) | 3.20726610 |
| 57 | tryptophan catabolic process (GO:0006569) | 3.20012594 |
| 58 | indole-containing compound catabolic process (GO:0042436) | 3.20012594 |
| 59 | indolalkylamine catabolic process (GO:0046218) | 3.20012594 |
| 60 | toxin transport (GO:1901998) | 3.19130851 |
| 61 | ribosomal small subunit assembly (GO:0000028) | 3.18741599 |
| 62 | high-density lipoprotein particle remodeling (GO:0034375) | 3.17961250 |
| 63 | sulfur amino acid catabolic process (GO:0000098) | 3.14823341 |
| 64 | regulation of natural killer cell differentiation (GO:0032823) | 3.14133731 |
| 65 | bile acid and bile salt transport (GO:0015721) | 3.14000009 |
| 66 | negative regulation of cholesterol transport (GO:0032375) | 3.13942729 |
| 67 | negative regulation of sterol transport (GO:0032372) | 3.13942729 |
| 68 | tryptophan metabolic process (GO:0006568) | 3.11580737 |
| 69 | regulation of extracellular matrix disassembly (GO:0010715) | 3.11129751 |
| 70 | endosome to pigment granule transport (GO:0043485) | 3.08928710 |
| 71 | endosome to melanosome transport (GO:0035646) | 3.08928710 |
| 72 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.07732013 |
| 73 | arginine metabolic process (GO:0006525) | 3.05251294 |
| 74 | platelet dense granule organization (GO:0060155) | 3.02827158 |
| 75 | cysteine metabolic process (GO:0006534) | 3.01165963 |
| 76 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.99470901 |
| 77 | alkaloid metabolic process (GO:0009820) | 2.98966706 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 2.97850825 |
| 79 | surfactant homeostasis (GO:0043129) | 2.97246163 |
| 80 | tricarboxylic acid metabolic process (GO:0072350) | 2.96446491 |
| 81 | glycosphingolipid catabolic process (GO:0046479) | 2.95716859 |
| 82 | negative regulation of hemostasis (GO:1900047) | 2.93132935 |
| 83 | negative regulation of blood coagulation (GO:0030195) | 2.93132935 |
| 84 | signal peptide processing (GO:0006465) | 2.91880288 |
| 85 | definitive hemopoiesis (GO:0060216) | 2.91155254 |
| 86 | oligosaccharide catabolic process (GO:0009313) | 2.90646652 |
| 87 | oxidative demethylation (GO:0070989) | 2.90574196 |
| 88 | regulation of humoral immune response (GO:0002920) | 2.89207717 |
| 89 | positive regulation of antigen processing and presentation (GO:0002579) | 2.88069684 |
| 90 | hormone catabolic process (GO:0042447) | 2.84363540 |
| 91 | branched-chain amino acid metabolic process (GO:0009081) | 2.82876841 |
| 92 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.80745613 |
| 93 | eosinophil chemotaxis (GO:0048245) | 2.79630342 |
| 94 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.79622638 |
| 95 | nitric oxide biosynthetic process (GO:0006809) | 2.77622894 |
| 96 | negative regulation of coagulation (GO:0050819) | 2.76907932 |
| 97 | regulation of bile acid biosynthetic process (GO:0070857) | 2.75607286 |
| 98 | glycolipid catabolic process (GO:0019377) | 2.75218333 |
| 99 | vitamin D metabolic process (GO:0042359) | 2.74038452 |
| 100 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.73710944 |
| 101 | heme transport (GO:0015886) | 2.73071179 |
| 102 | sphingolipid catabolic process (GO:0030149) | 2.72643362 |
| 103 | renal absorption (GO:0070293) | 2.71851049 |
| 104 | ethanol oxidation (GO:0006069) | 2.68596472 |
| 105 | response to type I interferon (GO:0034340) | 2.66902956 |
| 106 | cellular response to type I interferon (GO:0071357) | 2.65732027 |
| 107 | type I interferon signaling pathway (GO:0060337) | 2.65732027 |
| 108 | negative regulation of wound healing (GO:0061045) | 2.64835600 |
| 109 | S-adenosylmethionine metabolic process (GO:0046500) | 2.64185222 |
| 110 | bile acid biosynthetic process (GO:0006699) | 2.62885699 |
| 111 | intestinal absorption (GO:0050892) | 2.61714357 |
| 112 | imidazole-containing compound metabolic process (GO:0052803) | 2.61388860 |
| 113 | mature B cell differentiation involved in immune response (GO:0002313) | 2.61287128 |
| 114 | response to thyroid hormone (GO:0097066) | 2.60807418 |
| 115 | xenobiotic catabolic process (GO:0042178) | 2.60606305 |
| 116 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.60243491 |
| 117 | membrane lipid catabolic process (GO:0046466) | 2.59393039 |
| 118 | plasma lipoprotein particle organization (GO:0071827) | 2.58722764 |
| 119 | kynurenine metabolic process (GO:0070189) | 2.57823327 |
| 120 | NIK/NF-kappaB signaling (GO:0038061) | 2.57724103 |
| 121 | acute inflammatory response (GO:0002526) | 2.57638178 |
| 122 | ketone body metabolic process (GO:1902224) | 2.56573640 |
| 123 | adhesion of symbiont to host cell (GO:0044650) | 2.56268956 |
| 124 | virion attachment to host cell (GO:0019062) | 2.56268956 |
| 125 | positive regulation of lipid catabolic process (GO:0050996) | 2.55456474 |
| 126 | complement activation, alternative pathway (GO:0006957) | 2.55256980 |
| 127 | amino-acid betaine metabolic process (GO:0006577) | 2.54975238 |
| 128 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.54914047 |
| 129 | lysine catabolic process (GO:0006554) | 2.54805690 |
| 130 | lysine metabolic process (GO:0006553) | 2.54805690 |
| 131 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.54439561 |
| 132 | organic cation transport (GO:0015695) | 2.54095212 |
| 133 | primary alcohol metabolic process (GO:0034308) | 2.52404327 |
| 134 | macroautophagy (GO:0016236) | 2.52271533 |
| 135 | regulation of lipoprotein particle clearance (GO:0010984) | 2.51285983 |
| 136 | alpha-linolenic acid metabolic process (GO:0036109) | 2.50476062 |
| 137 | myeloid dendritic cell differentiation (GO:0043011) | 2.50438469 |
| 138 | response to nitrosative stress (GO:0051409) | 2.50149059 |
| 139 | benzene-containing compound metabolic process (GO:0042537) | 2.50084941 |
| 140 | T-helper 1 type immune response (GO:0042088) | 2.49494775 |
| 141 | regulation of natural killer cell activation (GO:0032814) | 2.48270032 |
| 142 | regulation of antigen processing and presentation (GO:0002577) | 2.47757788 |
| 143 | positive regulation of respiratory burst (GO:0060267) | 2.45832911 |
| 144 | phospholipid scrambling (GO:0017121) | 2.45762882 |
| 145 | dendritic cell differentiation (GO:0097028) | 2.45289896 |
| 146 | fatty acid oxidation (GO:0019395) | 2.43710215 |
| 147 | fatty acid beta-oxidation (GO:0006635) | 2.43684018 |
| 148 | flavonoid metabolic process (GO:0009812) | 2.42791730 |
| 149 | positive regulation of natural killer cell activation (GO:0032816) | 2.41972560 |
| 150 | branched-chain amino acid catabolic process (GO:0009083) | 2.41310074 |
| 151 | regulation of cholesterol esterification (GO:0010872) | 2.40520986 |
| 152 | lipid oxidation (GO:0034440) | 2.40405485 |
| 153 | myeloid dendritic cell activation (GO:0001773) | 2.40312221 |
| 154 | NAD biosynthetic process (GO:0009435) | 2.38218298 |
| 155 | aromatic amino acid family metabolic process (GO:0009072) | 2.34453055 |
| 156 | primary alcohol catabolic process (GO:0034310) | 2.34345736 |
| 157 | low-density lipoprotein particle remodeling (GO:0034374) | 2.34228984 |
| 158 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.33709059 |
| 159 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.33709059 |
| 160 | detection of other organism (GO:0098543) | 2.32175115 |
| 161 | protein carboxylation (GO:0018214) | 2.30699055 |
| 162 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.30699055 |
| 163 | 2-oxoglutarate metabolic process (GO:0006103) | 2.30655396 |
| 164 | acute-phase response (GO:0006953) | 2.30551858 |
| 165 | complement activation, classical pathway (GO:0006958) | 2.30101559 |
| 166 | drug catabolic process (GO:0042737) | 2.30069622 |
| 167 | secretory granule organization (GO:0033363) | 2.29876868 |
| 168 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.29371404 |
| 169 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.28303820 |
| 170 | glycoside metabolic process (GO:0016137) | 2.27855898 |
| 171 | carnitine metabolic process (GO:0009437) | 2.27725493 |
| 172 | reverse cholesterol transport (GO:0043691) | 2.27170812 |
| 173 | urea cycle (GO:0000050) | 2.26039167 |
| 174 | urea metabolic process (GO:0019627) | 2.26039167 |
| 175 | growth hormone receptor signaling pathway (GO:0060396) | 2.25772832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.49125660 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.79226145 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.09913145 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.09616977 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.61368106 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.59338845 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.41507182 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.12249715 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.04726770 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.02215294 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.00897912 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.93754791 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.81603818 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.68508494 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.56714135 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.53201216 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.49187853 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41312510 |
| 19 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19707540 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.19419832 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15169467 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.13899526 |
| 23 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.12073808 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.11697094 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11258130 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.10915655 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.95251939 |
| 28 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.90038877 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89590726 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.89502148 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.87718083 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84549320 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76051749 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.75673536 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.72627292 |
| 36 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.71799685 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.69976952 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67424206 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67150947 |
| 40 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62567490 |
| 41 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.59728039 |
| 42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57106528 |
| 43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.52036668 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50687766 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50226469 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48394395 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48280454 |
| 48 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.46090459 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.43792187 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.38205411 |
| 51 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.37770761 |
| 52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37379673 |
| 53 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.36726860 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36304800 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34564985 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34383313 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32897621 |
| 58 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32063542 |
| 59 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.30667047 |
| 60 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.29830310 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25330147 |
| 62 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24655067 |
| 63 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23580001 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.22711589 |
| 65 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22328073 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20304870 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19949592 |
| 68 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19518206 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 1.18451314 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17107012 |
| 71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16914828 |
| 72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16842873 |
| 73 | MAF_26560356_Chip-Seq_TH1_Human | 1.16684104 |
| 74 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.16297918 |
| 75 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13785135 |
| 76 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13105122 |
| 77 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.10851526 |
| 78 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10607298 |
| 79 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.10260317 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09062949 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08550566 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06414121 |
| 83 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.05601092 |
| 84 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04336777 |
| 85 | MYB_26560356_Chip-Seq_TH1_Human | 1.03285530 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01059839 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00222661 |
| 88 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99561528 |
| 89 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97573809 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96469163 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95810310 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95103977 |
| 93 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94408457 |
| 94 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94395348 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94127808 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91085097 |
| 97 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91044554 |
| 98 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90021495 |
| 99 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89871804 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89751909 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89630852 |
| 102 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89482319 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89461594 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88855420 |
| 105 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.88717623 |
| 106 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.88556360 |
| 107 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.88292000 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88195838 |
| 109 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.86353601 |
| 110 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.86072849 |
| 111 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85635152 |
| 112 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85271215 |
| 113 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.85101485 |
| 114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85096386 |
| 115 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.84780802 |
| 116 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.83805933 |
| 117 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81484561 |
| 118 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80868840 |
| 119 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80439017 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80080688 |
| 121 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80012150 |
| 122 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79857048 |
| 123 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79834891 |
| 124 | AR_20517297_ChIP-Seq_VCAP_Human | 0.78906518 |
| 125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77655449 |
| 126 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77591758 |
| 127 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.75645526 |
| 128 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.73309013 |
| 129 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.73083949 |
| 130 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.71869426 |
| 131 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.71839608 |
| 132 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71806901 |
| 133 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.70412252 |
| 134 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.70383096 |
| 135 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69670104 |
| 136 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69245768 |
| 137 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69245519 |
| 138 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.67345327 |
| 139 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.66710221 |
| 140 | CBP_21632823_ChIP-Seq_H3396_Human | 0.66010038 |
| 141 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.65380115 |
| 142 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.64939258 |
| 143 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.64683661 |
| 144 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.63415858 |
| 145 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.63056662 |
| 146 | NFYA_21822215_ChIP-Seq_K562_Human | 0.62906556 |
| 147 | SA1_27219007_Chip-Seq_Bcells_Human | 0.62855937 |
| 148 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.62766387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.53316699 |
| 2 | MP0002254_reproductive_system_inflammat | 3.52953243 |
| 3 | MP0005360_urolithiasis | 3.31161955 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.13519492 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 3.11335474 |
| 6 | MP0000685_abnormal_immune_system | 3.07597796 |
| 7 | MP0005365_abnormal_bile_salt | 2.81653126 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.73718472 |
| 9 | MP0003724_increased_susceptibility_to | 2.57662085 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.57505684 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.21013760 |
| 12 | MP0009785_altered_susceptibility_to | 2.17777581 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.09353159 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 1.97995674 |
| 15 | MP0009643_abnormal_urine_homeostasis | 1.92903269 |
| 16 | MP0002876_abnormal_thyroid_physiology | 1.89419169 |
| 17 | MP0003252_abnormal_bile_duct | 1.87648571 |
| 18 | MP0003300_gastrointestinal_ulcer | 1.82892257 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.80952066 |
| 20 | MP0005332_abnormal_amino_acid | 1.79925186 |
| 21 | MP0010368_abnormal_lymphatic_system | 1.79356172 |
| 22 | MP0000604_amyloidosis | 1.74557844 |
| 23 | MP0001873_stomach_inflammation | 1.73555012 |
| 24 | MP0005025_abnormal_response_to | 1.66855526 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 1.64820592 |
| 26 | MP0005671_abnormal_response_to | 1.64020802 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.63282161 |
| 28 | MP0001790_abnormal_immune_system | 1.61374801 |
| 29 | MP0005387_immune_system_phenotype | 1.61374801 |
| 30 | MP0005379_endocrine/exocrine_gland_phen | 1.59488152 |
| 31 | MP0003303_peritoneal_inflammation | 1.58988871 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.58962017 |
| 33 | MP0009840_abnormal_foam_cell | 1.58943384 |
| 34 | MP0001853_heart_inflammation | 1.58709272 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.54998275 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.54494341 |
| 37 | MP0010329_abnormal_lipoprotein_level | 1.52180273 |
| 38 | MP0003195_calcinosis | 1.51887127 |
| 39 | MP0001666_abnormal_nutrient_absorption | 1.51405935 |
| 40 | MP0009764_decreased_sensitivity_to | 1.51281582 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.50962256 |
| 42 | MP0003436_decreased_susceptibility_to | 1.49056015 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 1.43106633 |
| 44 | MP0005083_abnormal_biliary_tract | 1.41835303 |
| 45 | MP0003186_abnormal_redox_activity | 1.41190356 |
| 46 | MP0002419_abnormal_innate_immunity | 1.40658464 |
| 47 | MP0008469_abnormal_protein_level | 1.40182531 |
| 48 | MP0003879_abnormal_hair_cell | 1.36774465 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.36580444 |
| 50 | MP0005310_abnormal_salivary_gland | 1.35488786 |
| 51 | MP0006054_spinal_hemorrhage | 1.31684068 |
| 52 | MP0005058_abnormal_lysosome_morphology | 1.31203828 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.31156866 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.29372805 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.27667651 |
| 56 | MP0002136_abnormal_kidney_physiology | 1.25187876 |
| 57 | MP0005000_abnormal_immune_tolerance | 1.24909740 |
| 58 | MP0005166_decreased_susceptibility_to | 1.24395933 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 1.23973952 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 1.23826570 |
| 61 | MP0000609_abnormal_liver_physiology | 1.23731088 |
| 62 | MP0003868_abnormal_feces_composition | 1.22809371 |
| 63 | MP0001800_abnormal_humoral_immune | 1.20410485 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.18719820 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.18719820 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 1.18307242 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.18152173 |
| 68 | MP0002452_abnormal_antigen_presenting | 1.17451520 |
| 69 | MP0001348_abnormal_lacrimal_gland | 1.16854646 |
| 70 | MP0003690_abnormal_glial_cell | 1.16103696 |
| 71 | MP0009780_abnormal_chondrocyte_physiolo | 1.15729257 |
| 72 | MP0001756_abnormal_urination | 1.15355747 |
| 73 | MP0001958_emphysema | 1.14587342 |
| 74 | MP0002723_abnormal_immune_serum | 1.14571048 |
| 75 | MP0006082_CNS_inflammation | 1.13982071 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 1.13499980 |
| 77 | MP0002693_abnormal_pancreas_physiology | 1.12820536 |
| 78 | MP0002928_abnormal_bile_duct | 1.11343255 |
| 79 | MP0001764_abnormal_homeostasis | 1.10592281 |
| 80 | MP0005220_abnormal_exocrine_pancreas | 1.10472975 |
| 81 | MP0005535_abnormal_body_temperature | 1.09929637 |
| 82 | MP0000013_abnormal_adipose_tissue | 1.09736151 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 1.09487300 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09415799 |
| 85 | MP0003638_abnormal_response/metabolism_ | 1.08533668 |
| 86 | MP0003866_abnormal_defecation | 1.06854505 |
| 87 | MP0003329_amyloid_beta_deposits | 1.02836233 |
| 88 | MP0002118_abnormal_lipid_homeostasis | 1.02743997 |
| 89 | MP0001819_abnormal_immune_cell | 1.01536110 |
| 90 | MP0005448_abnormal_energy_balance | 1.01432055 |
| 91 | MP0002420_abnormal_adaptive_immunity | 1.01203278 |
| 92 | MP0002405_respiratory_system_inflammati | 1.01092415 |
| 93 | MP0001944_abnormal_pancreas_morphology | 1.00342316 |
| 94 | MP0001765_abnormal_ion_homeostasis | 1.00272850 |
| 95 | MP0004510_myositis | 0.98844813 |
| 96 | MP0009278_abnormal_bone_marrow | 0.97667394 |
| 97 | MP0004264_abnormal_extraembryonic_tissu | 0.95618165 |
| 98 | MP0001501_abnormal_sleep_pattern | 0.95530354 |
| 99 | MP0001533_abnormal_skeleton_physiology | 0.95349633 |
| 100 | MP0003806_abnormal_nucleotide_metabolis | 0.92239486 |
| 101 | MP0004147_increased_porphyrin_level | 0.91488376 |
| 102 | MP0002006_tumorigenesis | 0.91464155 |
| 103 | MP0000598_abnormal_liver_morphology | 0.90907887 |
| 104 | MP0000343_altered_response_to | 0.90442184 |
| 105 | MP0009763_increased_sensitivity_to | 0.89878676 |
| 106 | MP0002971_abnormal_brown_adipose | 0.86990206 |
| 107 | MP0003763_abnormal_thymus_physiology | 0.86411404 |
| 108 | MP0001346_abnormal_lacrimal_gland | 0.85655330 |
| 109 | MP0003943_abnormal_hepatobiliary_system | 0.85276001 |
| 110 | MP0004808_abnormal_hematopoietic_stem | 0.84865432 |
| 111 | MP0004947_skin_inflammation | 0.84569342 |
| 112 | MP0000716_abnormal_immune_system | 0.84221297 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.84150974 |
| 114 | MP0003075_altered_response_to | 0.81769398 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.79006374 |
| 116 | MP0009379_abnormal_foot_pigmentation | 0.78381624 |
| 117 | MP0002998_abnormal_bone_remodeling | 0.77470790 |
| 118 | MP0003011_delayed_dark_adaptation | 0.76828082 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.75986305 |
| 120 | MP0005645_abnormal_hypothalamus_physiol | 0.75237669 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.74967119 |
| 122 | MP0000689_abnormal_spleen_morphology | 0.74863485 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.74553393 |
| 124 | MP0003172_abnormal_lysosome_physiology | 0.74437925 |
| 125 | MP0002135_abnormal_kidney_morphology | 0.73706627 |
| 126 | MP0004043_abnormal_pH_regulation | 0.69446336 |
| 127 | MP0005451_abnormal_body_composition | 0.66325636 |
| 128 | MP0005164_abnormal_response_to | 0.65894727 |
| 129 | MP0003953_abnormal_hormone_level | 0.65750625 |
| 130 | MP0000538_abnormal_urinary_bladder | 0.63044293 |
| 131 | MP0004270_analgesia | 0.62959561 |
| 132 | MP0005376_homeostasis/metabolism_phenot | 0.62001518 |
| 133 | MP0005408_hypopigmentation | 0.59711295 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.58649329 |
| 135 | MP0001664_abnormal_digestion | 0.58523238 |
| 136 | MP0002163_abnormal_gland_morphology | 0.58252805 |
| 137 | MP0001663_abnormal_digestive_system | 0.57836067 |
| 138 | MP0000249_abnormal_blood_vessel | 0.56704866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 4.24862853 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.14601202 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.14186425 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.14186425 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.14186425 |
| 6 | Malnutrition (HP:0004395) | 3.62897645 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 3.60629862 |
| 8 | Interstitial pulmonary disease (HP:0006530) | 3.45616556 |
| 9 | Myositis (HP:0100614) | 3.35748118 |
| 10 | Gout (HP:0001997) | 3.34513353 |
| 11 | Generalized aminoaciduria (HP:0002909) | 3.34024180 |
| 12 | Thrombocytosis (HP:0001894) | 3.30850713 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.28087209 |
| 14 | Increased CSF protein (HP:0002922) | 3.09016832 |
| 15 | Nephritis (HP:0000123) | 3.05322843 |
| 16 | Hyperactive renin-angiotensin system (HP:0000841) | 3.05105508 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.05087300 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.02499116 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 2.92424579 |
| 20 | Conjugated hyperbilirubinemia (HP:0002908) | 2.88778481 |
| 21 | Abnormality of purine metabolism (HP:0004352) | 2.88336473 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.77288836 |
| 23 | Hypokalemic alkalosis (HP:0001949) | 2.73154378 |
| 24 | Complement deficiency (HP:0004431) | 2.73066281 |
| 25 | Intrahepatic cholestasis (HP:0001406) | 2.71549982 |
| 26 | Progressive neurologic deterioration (HP:0002344) | 2.71241720 |
| 27 | Hypoglycemic coma (HP:0001325) | 2.71233284 |
| 28 | Abnormality of vitamin metabolism (HP:0100508) | 2.69596583 |
| 29 | Hypolipoproteinemia (HP:0010981) | 2.68380494 |
| 30 | Abnormality of proline metabolism (HP:0010907) | 2.67732162 |
| 31 | Hydroxyprolinuria (HP:0003080) | 2.67732162 |
| 32 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.64282557 |
| 33 | Ketoacidosis (HP:0001993) | 2.62418539 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.60784740 |
| 35 | Ketosis (HP:0001946) | 2.58981729 |
| 36 | Loss of speech (HP:0002371) | 2.57142400 |
| 37 | Deep venous thrombosis (HP:0002625) | 2.54710195 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 2.53729003 |
| 39 | Xanthomatosis (HP:0000991) | 2.50186880 |
| 40 | Impaired platelet aggregation (HP:0003540) | 2.49506530 |
| 41 | Abnormal platelet function (HP:0011869) | 2.49506530 |
| 42 | Prolonged partial thromboplastin time (HP:0003645) | 2.49081116 |
| 43 | Alkalosis (HP:0001948) | 2.45331339 |
| 44 | Esophageal varix (HP:0002040) | 2.45052069 |
| 45 | Joint hemorrhage (HP:0005261) | 2.44212644 |
| 46 | Abnormality of chloride homeostasis (HP:0011422) | 2.43191361 |
| 47 | Nuclear cataract (HP:0100018) | 2.41357191 |
| 48 | Orchitis (HP:0100796) | 2.41276187 |
| 49 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.38641004 |
| 50 | Hyperglycinuria (HP:0003108) | 2.37878578 |
| 51 | Steatorrhea (HP:0002570) | 2.37599016 |
| 52 | Eczematoid dermatitis (HP:0000976) | 2.36984818 |
| 53 | Epistaxis (HP:0000421) | 2.36863551 |
| 54 | Renal salt wasting (HP:0000127) | 2.36803721 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.35981782 |
| 56 | Hyperammonemia (HP:0001987) | 2.35924352 |
| 57 | Abnormality of vitamin B metabolism (HP:0004340) | 2.35026896 |
| 58 | Recurrent bacterial skin infections (HP:0005406) | 2.34491678 |
| 59 | Increased cerebral lipofuscin (HP:0011813) | 2.33847370 |
| 60 | Cardiovascular calcification (HP:0011915) | 2.32075689 |
| 61 | Proximal tubulopathy (HP:0000114) | 2.31071156 |
| 62 | Abnormality of nucleobase metabolism (HP:0010932) | 2.30816505 |
| 63 | Abnormality of renal excretion (HP:0011036) | 2.30774411 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.30689848 |
| 65 | Abnormality of the common coagulation pathway (HP:0010990) | 2.30494123 |
| 66 | Hyperuricemia (HP:0002149) | 2.29879061 |
| 67 | Increased purine levels (HP:0004368) | 2.29879061 |
| 68 | Gingival bleeding (HP:0000225) | 2.27965914 |
| 69 | Congenital sensorineural hearing impairment (HP:0008527) | 2.27899917 |
| 70 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.27252996 |
| 71 | Chronic otitis media (HP:0000389) | 2.25429616 |
| 72 | Glomerulonephritis (HP:0000099) | 2.21721631 |
| 73 | Prolonged bleeding time (HP:0003010) | 2.17630571 |
| 74 | Mucopolysacchariduria (HP:0008155) | 2.17275764 |
| 75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17275764 |
| 76 | Cardiomegaly (HP:0001640) | 2.16997587 |
| 77 | Irritability (HP:0000737) | 2.16821332 |
| 78 | Petechiae (HP:0000967) | 2.16224643 |
| 79 | Delayed CNS myelination (HP:0002188) | 2.16080034 |
| 80 | Thrombophlebitis (HP:0004418) | 2.14476347 |
| 81 | IgM deficiency (HP:0002850) | 2.14270696 |
| 82 | Reduced antithrombin III activity (HP:0001976) | 2.13130072 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.13029665 |
| 84 | Abnormal urine output (HP:0012590) | 2.11469233 |
| 85 | Dysostosis multiplex (HP:0000943) | 2.08737985 |
| 86 | Arterial thrombosis (HP:0004420) | 2.08380682 |
| 87 | Polyuria (HP:0000103) | 2.08285006 |
| 88 | Hyperaldosteronism (HP:0000859) | 2.08172614 |
| 89 | Renal tubular acidosis (HP:0001947) | 2.08138671 |
| 90 | Abnormality of complement system (HP:0005339) | 2.08054063 |
| 91 | Epidermoid cyst (HP:0200040) | 2.08051564 |
| 92 | Hematochezia (HP:0002573) | 2.07066018 |
| 93 | Prolonged neonatal jaundice (HP:0006579) | 2.05953607 |
| 94 | Late onset (HP:0003584) | 2.05077474 |
| 95 | Amyloidosis (HP:0011034) | 2.04929519 |
| 96 | Protuberant abdomen (HP:0001538) | 2.03472234 |
| 97 | Abnormality of urine glucose concentration (HP:0011016) | 2.02677220 |
| 98 | Glycosuria (HP:0003076) | 2.02677220 |
| 99 | Metabolic alkalosis (HP:0200114) | 2.02451009 |
| 100 | Dicarboxylic aciduria (HP:0003215) | 2.02035410 |
| 101 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02035410 |
| 102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.01392930 |
| 103 | Abnormality of renin-angiotensin system (HP:0000847) | 2.00685956 |
| 104 | Hypophosphatemia (HP:0002148) | 1.99655001 |
| 105 | Beaking of vertebral bodies (HP:0004568) | 1.98463772 |
| 106 | Pulmonary embolism (HP:0002204) | 1.98168863 |
| 107 | Recurrent skin infections (HP:0001581) | 1.97375948 |
| 108 | Recurrent abscess formation (HP:0002722) | 1.97265398 |
| 109 | Increased circulating renin level (HP:0000848) | 1.96184249 |
| 110 | Vascular calcification (HP:0004934) | 1.94296979 |
| 111 | Onycholysis (HP:0001806) | 1.93655813 |
| 112 | Hypoalphalipoproteinemia (HP:0003233) | 1.93156256 |
| 113 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93062910 |
| 114 | Abnormality of magnesium homeostasis (HP:0004921) | 1.92004231 |
| 115 | Colitis (HP:0002583) | 1.91661273 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 1.90768736 |
| 117 | Hyperglycemia (HP:0003074) | 1.89865790 |
| 118 | J-shaped sella turcica (HP:0002680) | 1.89309623 |
| 119 | Polycythemia (HP:0001901) | 1.89245616 |
| 120 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89205908 |
| 121 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89205908 |
| 122 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89205908 |
| 123 | Menorrhagia (HP:0000132) | 1.88811050 |
| 124 | Retinal atrophy (HP:0001105) | 1.88548853 |
| 125 | Skin nodule (HP:0200036) | 1.88462034 |
| 126 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.88273636 |
| 127 | Abnormality of glycine metabolism (HP:0010895) | 1.88273636 |
| 128 | Vertebral compression fractures (HP:0002953) | 1.88255246 |
| 129 | Fat malabsorption (HP:0002630) | 1.88036918 |
| 130 | Abnormality of macrophages (HP:0004311) | 1.87556439 |
| 131 | Hypomagnesemia (HP:0002917) | 1.87403710 |
| 132 | Pancreatitis (HP:0001733) | 1.86943438 |
| 133 | Mitral stenosis (HP:0001718) | 1.86314608 |
| 134 | Metabolic acidosis (HP:0001942) | 1.85172713 |
| 135 | Periodontitis (HP:0000704) | 1.85114842 |
| 136 | Optic neuritis (HP:0100653) | 1.84140484 |
| 137 | Retrobulbar optic neuritis (HP:0100654) | 1.84140484 |
| 138 | Purpura (HP:0000979) | 1.84052303 |
| 139 | Hypoglycemic seizures (HP:0002173) | 1.82875376 |
| 140 | Rickets (HP:0002748) | 1.82787644 |
| 141 | Hypothermia (HP:0002045) | 1.82665106 |
| 142 | Joint swelling (HP:0001386) | 1.81019596 |
| 143 | Potter facies (HP:0002009) | 1.80977409 |
| 144 | Facial shape deformation (HP:0011334) | 1.80977409 |
| 145 | Increased serum ferritin (HP:0003281) | 1.79430086 |
| 146 | Hemorrhage of the eye (HP:0011885) | 1.75769809 |
| 147 | Bone cyst (HP:0012062) | 1.75695103 |
| 148 | Abdominal distention (HP:0003270) | 1.74709705 |
| 149 | Chronic diarrhea (HP:0002028) | 1.72872430 |
| 150 | Axonal loss (HP:0003447) | 1.72629046 |
| 151 | Hyperphosphaturia (HP:0003109) | 1.71687149 |
| 152 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71381460 |
| 153 | Myocardial infarction (HP:0001658) | 1.71161457 |
| 154 | Hypotension (HP:0002615) | 1.71142740 |
| 155 | Stroke (HP:0001297) | 1.70600637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 3.25999604 |
| 2 | ERN1 | 3.20643500 |
| 3 | TIE1 | 3.16500849 |
| 4 | TGFBR2 | 2.77139208 |
| 5 | BCKDK | 2.73949052 |
| 6 | KIT | 2.53512979 |
| 7 | FLT3 | 2.52577814 |
| 8 | MAPK15 | 2.47452633 |
| 9 | TGFBR1 | 2.46561975 |
| 10 | MAP3K14 | 2.40723577 |
| 11 | TBK1 | 2.28696238 |
| 12 | FGFR4 | 2.12608934 |
| 13 | TAOK1 | 2.08830558 |
| 14 | TYK2 | 1.98806472 |
| 15 | JAK3 | 1.97447087 |
| 16 | TEC | 1.93222918 |
| 17 | EPHA3 | 1.92550385 |
| 18 | BTK | 1.91171107 |
| 19 | IRAK3 | 1.83519925 |
| 20 | IRAK4 | 1.77088534 |
| 21 | IKBKE | 1.76786143 |
| 22 | DAPK2 | 1.73412828 |
| 23 | EPHB1 | 1.65079599 |
| 24 | GRK7 | 1.65006251 |
| 25 | TNK2 | 1.62971958 |
| 26 | ZAP70 | 1.61433930 |
| 27 | TAOK3 | 1.56859885 |
| 28 | KDR | 1.56755246 |
| 29 | IKBKB | 1.56053160 |
| 30 | NLK | 1.50714263 |
| 31 | NME2 | 1.50681381 |
| 32 | INSRR | 1.49302092 |
| 33 | MAP2K3 | 1.43826375 |
| 34 | CDC42BPA | 1.43722901 |
| 35 | MAP3K2 | 1.41301688 |
| 36 | PIM2 | 1.39515583 |
| 37 | MATK | 1.39290967 |
| 38 | CHUK | 1.38792674 |
| 39 | SIK1 | 1.30653536 |
| 40 | PTK6 | 1.30638248 |
| 41 | MAP4K1 | 1.29469858 |
| 42 | MYLK | 1.29207146 |
| 43 | TRPM7 | 1.23168968 |
| 44 | LRRK2 | 1.19827833 |
| 45 | RIPK4 | 1.19608106 |
| 46 | DYRK1B | 1.18207074 |
| 47 | MAP3K3 | 1.13353677 |
| 48 | FRK | 1.13050178 |
| 49 | MAP2K2 | 1.10012773 |
| 50 | MAP3K12 | 1.09764010 |
| 51 | PIK3CG | 1.08061662 |
| 52 | DYRK3 | 1.07464392 |
| 53 | CSF1R | 1.06489166 |
| 54 | PRKG2 | 1.02572451 |
| 55 | TRIB3 | 1.01819180 |
| 56 | RIPK1 | 1.00971563 |
| 57 | EPHA2 | 0.99578225 |
| 58 | RPS6KB2 | 0.99132962 |
| 59 | BLK | 0.98379016 |
| 60 | IRAK1 | 0.98231675 |
| 61 | PHKG1 | 0.97438843 |
| 62 | PHKG2 | 0.97438843 |
| 63 | DDR2 | 0.96876118 |
| 64 | WNK4 | 0.96256911 |
| 65 | PDPK1 | 0.95375074 |
| 66 | JAK1 | 0.94941435 |
| 67 | MAP3K11 | 0.93040704 |
| 68 | NEK9 | 0.91817034 |
| 69 | STK16 | 0.91275388 |
| 70 | ADRBK2 | 0.91200498 |
| 71 | YES1 | 0.90384056 |
| 72 | TNIK | 0.89466666 |
| 73 | PINK1 | 0.87058607 |
| 74 | HIPK2 | 0.86170939 |
| 75 | FGFR2 | 0.86047145 |
| 76 | MUSK | 0.84706253 |
| 77 | MST4 | 0.83968366 |
| 78 | NTRK3 | 0.83210665 |
| 79 | ABL2 | 0.80411560 |
| 80 | BMPR2 | 0.79630053 |
| 81 | SYK | 0.78283930 |
| 82 | MAP2K6 | 0.78121427 |
| 83 | MAPKAPK3 | 0.77579528 |
| 84 | PKN2 | 0.75138678 |
| 85 | PDK1 | 0.75087991 |
| 86 | JAK2 | 0.74721567 |
| 87 | BMPR1B | 0.72955530 |
| 88 | FGFR3 | 0.72546495 |
| 89 | CAMK2D | 0.71562728 |
| 90 | WNK3 | 0.71105261 |
| 91 | MST1R | 0.70527530 |
| 92 | PRKACG | 0.70195604 |
| 93 | TXK | 0.69190548 |
| 94 | PAK4 | 0.68704229 |
| 95 | EEF2K | 0.67419457 |
| 96 | OXSR1 | 0.66191215 |
| 97 | TESK1 | 0.66089445 |
| 98 | PRKCE | 0.65870583 |
| 99 | MAPKAPK5 | 0.64088149 |
| 100 | PRKD2 | 0.62359733 |
| 101 | SIK3 | 0.61739501 |
| 102 | RPS6KA4 | 0.61103459 |
| 103 | CDK8 | 0.60331885 |
| 104 | PAK3 | 0.59427995 |
| 105 | PASK | 0.59424869 |
| 106 | TAOK2 | 0.58307665 |
| 107 | PRPF4B | 0.57992993 |
| 108 | CAMKK2 | 0.56578537 |
| 109 | LYN | 0.56291357 |
| 110 | ERBB3 | 0.55447021 |
| 111 | PRKAA2 | 0.54769135 |
| 112 | FGR | 0.54132722 |
| 113 | GRK6 | 0.53224819 |
| 114 | MAPK11 | 0.53162421 |
| 115 | MAP4K2 | 0.51751783 |
| 116 | MAPKAPK2 | 0.50035951 |
| 117 | PIK3CA | 0.49474650 |
| 118 | PIM1 | 0.49441241 |
| 119 | MAP3K1 | 0.49141718 |
| 120 | PTK2 | 0.48751018 |
| 121 | LCK | 0.47303484 |
| 122 | MAP3K4 | 0.47070418 |
| 123 | IRAK2 | 0.45135608 |
| 124 | MAP3K13 | 0.43964509 |
| 125 | ITK | 0.43330328 |
| 126 | PRKCA | 0.42547180 |
| 127 | FES | 0.42446331 |
| 128 | ILK | 0.42131875 |
| 129 | PRKCZ | 0.42023700 |
| 130 | PRKCD | 0.41728187 |
| 131 | IGF1R | 0.41577121 |
| 132 | LMTK2 | 0.41421860 |
| 133 | SCYL2 | 0.40909876 |
| 134 | PRKG1 | 0.40160131 |
| 135 | CSK | 0.39110656 |
| 136 | MAPK4 | 0.38955153 |
| 137 | MAP3K7 | 0.38024140 |
| 138 | GRK1 | 0.37981396 |
| 139 | GSK3A | 0.37554749 |
| 140 | FER | 0.37334421 |
| 141 | HCK | 0.35743528 |
| 142 | STK24 | 0.35038278 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.90132547 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.82899186 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.58104502 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.47585090 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21965258 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.21473043 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.16404390 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.15430100 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.99248907 |
| 10 | Peroxisome_Homo sapiens_hsa04146 | 1.95016137 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.94410254 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92578027 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92260130 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.81690809 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.78898660 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77070368 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74819392 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69741139 |
| 19 | Protein export_Homo sapiens_hsa03060 | 1.64437132 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.63098497 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.61035041 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.58719332 |
| 23 | Sulfur relay system_Homo sapiens_hsa04122 | 1.52681809 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.44258547 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40156869 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39504686 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.36943781 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.34352903 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.32033833 |
| 30 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.31508589 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.30577694 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28396534 |
| 33 | Mineral absorption_Homo sapiens_hsa04978 | 1.28250807 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.27536835 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.25394737 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24854901 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.24699645 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.24695194 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.24649954 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.24446998 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22981002 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.22757191 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.20250552 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19637482 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.18185412 |
| 46 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.15885512 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.15192150 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.13467508 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12823203 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12211121 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.08554574 |
| 52 | Asthma_Homo sapiens_hsa05310 | 1.07142563 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06896586 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.03764657 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00023175 |
| 56 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.97325226 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96616804 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95692615 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95312674 |
| 60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93416642 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.92912331 |
| 62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91644554 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.91194412 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89697569 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.88534132 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.87406374 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.86198963 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85998244 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85625981 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83426978 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82993793 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82210272 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.81648901 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80894272 |
| 75 | Ribosome_Homo sapiens_hsa03010 | 0.80307267 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.80199742 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80047969 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80000121 |
| 79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78625329 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78487532 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.76808346 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.76594601 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.74801133 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.73830606 |
| 85 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.73757814 |
| 86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73482314 |
| 87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.71376486 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71095675 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69734631 |
| 90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69408469 |
| 91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67899294 |
| 92 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.66746336 |
| 93 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65795229 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62054960 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61806792 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61294535 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57175970 |
| 98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55348469 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54864786 |
| 100 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54825211 |
| 101 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54810680 |
| 102 | Influenza A_Homo sapiens_hsa05164 | 0.54466071 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53845841 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.53324806 |
| 105 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52287870 |
| 106 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.52201262 |
| 107 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50476606 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.49076037 |
| 109 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48984858 |
| 110 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48036956 |
| 111 | Tuberculosis_Homo sapiens_hsa05152 | 0.47905882 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47869422 |
| 113 | Allograft rejection_Homo sapiens_hsa05330 | 0.46231995 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45445401 |
| 115 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.44313391 |
| 116 | Insulin secretion_Homo sapiens_hsa04911 | 0.41500717 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40552840 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40462491 |
| 119 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40412531 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.39992576 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.39733001 |
| 122 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39689773 |
| 123 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39612667 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38418886 |
| 125 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38020104 |
| 126 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37936793 |
| 127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37807207 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37342969 |
| 129 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34048266 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24748122 |
| 131 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.24150225 |
| 132 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23813011 |
| 133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23730691 |
| 134 | Carbon metabolism_Homo sapiens_hsa01200 | 0.22602660 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.21242250 |
| 136 | Renin secretion_Homo sapiens_hsa04924 | 0.21014074 |

